Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Virology. 2021 Jan 28;556:39–61. doi: 10.1016/j.virol.2021.01.012

Figure 5:

Figure 5:

(A) SDS-PAGE fingerprint of protein corona formed on PEGylated PhMV particles after 1hour incubation with human plasma. (B) Pharmacokinetic profile of PEGylated PhMV (coloaded with Cy5.5 and Gd3+) in Balb/C mice following I.V. injection of 200 μg. Reprinted from [90], Copyright 2019, with permission from American Chemical Society.